Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Share-based Compensation: 2009-2024

Historic Share-based Compensation for Sunshine Biopharma (SBFM) over the last 14 years, with Dec 2024 value amounting to $12,000.

  • Sunshine Biopharma's Share-based Compensation was N/A to $12,000 in Q1 2024 from the same period last year, while for Mar 2024 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of $12,000 for FY2024, which is N/A change from last year.
  • Sunshine Biopharma's Share-based Compensation amounted to $12,000 in FY2024, which was down 98.69% from $918,000 recorded in FY2021.
  • Sunshine Biopharma's 5-year Share-based Compensation high stood at $918,000 for FY2021, and its period low was $12,000 during FY2024.
  • In the last 1 years, Sunshine Biopharma's Share-based Compensation had a median value of $12,000 in 2024 and averaged $12,000.
  • Per our database at Business Quant, Sunshine Biopharma's Share-based Compensation slumped by 80.89% in 2020 and then surged by 1,736.00% in 2021.
  • Yearly analysis of 3 years shows Sunshine Biopharma's Share-based Compensation stood at $50,000 in 2020, then spiked by 1,736.00% to $918,000 in 2021, then reached $12,000 in 2024.